OTC · Medical - Devices

BrainsWay Ltd. (BRSYF) Stock

$15.13 +0.00% OTC: BRSYF Healthcare

BrainsWay Ltd. is a global medical technology company focused on innovating and providing non-invasive neurostimulation therapies for a broad spectrum of mental health and neurological conditions.

Valuation

MetricValue
Price$15.13
Market Cap$607.19M
P/E Ratio71.21
P/B Ratio8.08
P/S Ratio10.64
EPS (TTM)$0.21
52-Week High$16.84
52-Week Low$5.49
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE12.28%
ROA7.54%
ROCE6.54%
Gross Margin75.50%
Operating Margin10.09%
Net Margin14.57%
Debt/Equity0.09
Current Ratio3.34

Annual Financials (USD)

Metric20212022202320242025
Revenue$30.0M$27.0M$32.0M$41.0M$57.0M
Operating Profit$-5.0M$-13.0M$-5.0M$1.0M$5.0M
Net Profit$-6.0M$-13.0M$-4.0M$3.0M$8.0M
EPS$-0.21$-0.40$-0.13$0.09$0.20
Op Margin-16.9%-46.7%-15.6%3.4%8.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$76.0M$64.0M$63.0M$94.0M$113.0M
Total Liabilities$18.0M$19.0M$21.0M$32.0M$35.0M
Cash$17.0M$48.0M$11.0M$69.0M$68.0M
Borrowings$1.0M$0$0$6.0M$7.0M

Latest News

BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026 GlobeNewswire · Jul 29, 2026 Brainsway and Lululemon athletica have been highlighted as Zacks Bull and Bear of the Day Zacks · Jul 24, 2026 Bull of the Day: Brainsway (BWAY) Zacks · Jul 24, 2026 Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable Zacks · Jul 22, 2026 Zacks Industry Outlook Highlights Terumo, QuidelOrtho, Lumexa Imaging and Brainsway Zacks · Jul 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$1.0M$-10.0M$1.0M$10.0M$20.0M
Investing Cash Flow$-44.0M$42.0M$-40.0M$27.0M$-21.0M
Financing Cash Flow$0$-1.0M$-1.0M$2.0M$-1.0M
Net Cash Flow$0$31.0M$-37.0M$59.0M$-2.0M
Free Cash Flow$-1.0M$-10.0M$-1.0M$7.0M$18.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.78
EV / EBITDA81.15
FCF Yield1.74%
Quick Ratio3.04
Interest Coverage2.89
Return 1Y123.16%
Return 3Y1581.11%
Return 5Y—

Ownership

Insiders Held9.52%
Institutions Held10.71%
Institutions Float Held11.83%
Institutional HolderSharesReport Date
Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund50,6272026-04-30
SEI INSTITUTIONAL INTERNATIONAL TRUST-SIT International Equity Fund2,3682026-05-31
SEI INSTITUTIONAL INVESTMENTS TRUST-SIIT World Equity EX-US Fund2,9502026-05-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BCCOYBICO Group AB (publ) $0.37 +0.00% -1.07 $104.11M 0.00%
CLLKFBICO Group AB (publ) $1.53 +0.00% -1.07 $105.68M 0.00%
CYBQFCYBERDYNE Inc. $1.55 +19.23% 305.56 $206.82M 0.00%
CYBQYCYBERDYNE Inc. $1.36 +0.00% 304.17 $241.65M 0.00%
GNFTFGenfit S.a. $15.95 +0.00% -8.14 $799.03M 0.00%

About BrainsWay Ltd.

BrainsWay Ltd. is a global medical technology company focused on innovating and providing non-invasive neurostimulation therapies for a broad spectrum of mental health and neurological conditions. Operating across the United States, Europe, Israel, and other international markets, the company's core offering is its Deep Transcranial Magnetic Stimulation (dTMS) platform. This advanced technology is employed in the treatment of numerous disorders, including severe depression, anxious depression, obsessive-compulsive disorder, smoking addiction, bipolar disorders, post-traumatic stress disorder, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's solutions are primarily adopted by psychiatrists, hospitals, and specialized medical centers. The company was established in 2003 and has its headquarters situated in Jerusalem, Israel.

BrainsWay Ltd. is headquartered in IL.

BrainsWay Ltd. (BRSYF) stock trades at $15.13 with a market capitalization of $607.19M. The stock is valued at a price-to-earnings (P/E) ratio of 71.21, price-to-book of 8.08, price-to-sales of 10.64. Over the past 52 weeks the stock has ranged between $5.49 and $16.84, and currently trades 10.2% below its 52-week high.

On profitability, BrainsWay Ltd. generates a return on equity (ROE) of 12.28%, above the typical market average, return on capital employed of 6.54%, an operating margin of 10.09%, a net profit margin of 14.57%.

Official website: www.brainsway.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides